GE HealthCare Technologies Inc. $GEHC Shares Sold by Eagle Rock Investment Company LLC

Eagle Rock Investment Company LLC reduced its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 50.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 29,262 shares of the company’s stock after selling 29,405 shares during the quarter. Eagle Rock Investment Company LLC’s holdings in GE HealthCare Technologies were worth $2,400,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of GEHC. Godsey & Gibb Inc. bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth $26,000. E Fund Management Hong Kong Co. Ltd. boosted its stake in GE HealthCare Technologies by 130.7% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after buying an additional 196 shares in the last quarter. Oakworth Capital Inc. boosted its stake in GE HealthCare Technologies by 1,876.2% during the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after buying an additional 394 shares in the last quarter. Piscataqua Savings Bank grew its holdings in GE HealthCare Technologies by 173.4% during the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after acquiring an additional 300 shares during the period. Finally, Salomon & Ludwin LLC raised its position in GE HealthCare Technologies by 326.5% in the third quarter. Salomon & Ludwin LLC now owns 482 shares of the company’s stock worth $37,000 after acquiring an additional 369 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Down 3.2%

NASDAQ:GEHC opened at $69.23 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $89.77. The firm has a market capitalization of $31.59 billion, a price-to-earnings ratio of 15.18, a price-to-earnings-growth ratio of 1.57 and a beta of 1.03. The stock has a fifty day simple moving average of $77.91 and a 200 day simple moving average of $78.26.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the previous year, the company earned $1.45 EPS. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. BTIG Research reissued a “buy” rating and issued a $91.00 price target on shares of GE HealthCare Technologies in a report on Thursday, March 19th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Jefferies Financial Group boosted their target price on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Stifel Nicolaus raised their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Finally, Morgan Stanley lifted their price target on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 4th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Hold” and an average price target of $92.17.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.